The latest news & events

Keep up to date with company updates, industry news, investor
press releases and event information.

Investor News : 12 May 2022

May 12, 2022 | Kneat Announces Record SaaS Revenue in Q1 2022

LIMERICK, Ireland, May 12, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”), a leader in digitizing and…

Read More
Investor News : 9 May 2022

May 9, 2022 | Kneat Announces Release Date for First Quarter Financial Results

LIMERICK, Ireland, May 9, 2022 /CNW/– kneat.com, inc. (TSX: KSI) (“Kneat” or the “Company”), a leader in digitizing and automating…

Read More
Events : 4 May 2022

Kneat to Exhibit at ISPE Singapore Conference & Exhibition 2022

ISPE Singapore Conference & Exhibition 2022 ISPE Singapore Conference & Exhibition 2022 takes place in Suntec and Online from the…

Read More
Events : 4 May 2022

Kneat to Exhibit at European QA Congress 2022

European QA Congress 2022 The European QA Congress 2022 takes place virtually on the 11th and 12th of May.  Organised…

Read More
Events : 27 Apr 2022

Kneat to Attend Pharma Talk EU

Pharma Talk EU Pharma Talk EU takes place in Berlin from 28th-29th June 2022.  PharmaTalk is a leading annual meeting…

Read More
Events : 27 Apr 2022

Kneat to Exhibit at Bio Talk USA

Bio Talk USA Bio Talk USA takes place in Boston from 8th-9th June 2022.  BioTalk is a leading annual meeting…

Read More
Investor News : 31 Mar 2022

March 31, 2022 | Kneat Announces OTCQX Listing and DTC Eligibility

LIMERICK, Ireland, March 31, 2022/CNW/ – kneat.com, inc. (TSX: KSI) (OTCQX: FBAYF) (“Kneat” or the “Company”) a leader in digitizing…

Read More
Investor News : 18 Mar 2022

March 18, 2022 | European National Health Service Selects Kneat’s eValidation Platform

LIMERICK, Ireland, March 18, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”), a leader in digitizing and…

Read More
Investor News : 17 Mar 2022

March 17, 2022 | Top Ten Biopharmaceutical Company Selects Kneat as its Enterprise Platform

Kneat Now Counts Eight of the Top Ten Global Pharmaceutical Companies as Customers LIMERICK, Ireland, March 17, 2022 /CNW/ –…

Read More
Investor News : 10 Mar 2022

March 10, 2022 | Leading Canadian Generics Pharmaceutical Manufacturer Selects Kneat’s SaaS E-Validation Platform

LIMERICK, Ireland, March 10, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”), a leader in digitizing and…

Read More
Events : 9 Mar 2022

Kneat to Exhibit at The ISPE Boston Product Show 2022

The ISPE Boston Product Show 2022 The ISPE Boston Product Show takes place at the Gillette Stadium in Boston on…

Read More
Events : 9 Mar 2022

Kneat to Feature at KENX Biopharmaceutical University

KENX Biopharmaceutical University KENX Biopharmaceutical University takes place in San Diego from 6th-8th June 2022.  More than ever before, the…

Read More

Sign Up to Our Newsletter

Contact

Talk to us

Find out how Kneat can make your validation easier, faster, and smarter.
Start your paperless validation revolution by speaking to our experts.

Europe: +353-61-203826
USA: 1 888 88 KNEAT
Canada: +1 902 706 9074